188
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Associations of Relative Fat Mass, a Novel Adiposity Indicator, with Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: Data from SPECT-China

, , , , & ORCID Icon
Pages 2377-2387 | Received 28 May 2023, Accepted 02 Aug 2023, Published online: 08 Aug 2023

References

  • González-Muniesa P, Mártinez-González M-A, Hu FB, et al. Obesity. Nat Rev Dis Primers. 2017;3:17034. doi:10.1038/nrdp.2017.34
  • Kyrgiou M, Kalliala I, Markozannes G, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ. 2017;356:j477. doi:10.1136/bmj.j477
  • Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American heart association. Circulation. 2021;143(21). doi:10.1161/CIR.0000000000000973
  • Piché M-E, Tchernof A, Després J-P. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477–1500. doi:10.1161/CIRCRESAHA.120.316101
  • Fan J-G, Kim S-U, Wong VW-S. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862–873. doi:10.1016/j.jhep.2017.06.003
  • Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17(6):510–519. doi:10.1111/obr.12407
  • Mandviwala T, Khalid U, Deswal A. Obesity and cardiovascular disease: a risk factor or a risk marker? Curr Atheroscler Rep. 2016;18(5):21. doi:10.1007/s11883-016-0575-4
  • Gutiérrez-Cuevas J, Santos A, Armendariz-Borunda J. Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases. Int J Mol Sci. 2021;22(21):11629. doi:10.3390/ijms222111629
  • Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Meza-Rios A, et al. Molecular mechanisms of obesity-linked cardiac dysfunction: an update on current knowledge. Cells. 2021;10(3):629.
  • Gutiérrez-Cuevas J, Lucano-Landeros S, López-Cifuentes D, Santos A, Armendariz-Borunda J. Epidemiologic, genetic, pathogenic, metabolic, epigenetic aspects involved in NASH-HCC: current therapeutic strategies. Cancers. 2022;15(1). doi:10.3390/cancers15010023
  • Duren DL, Sherwood RJ, Czerwinski SA, et al. Body composition methods: comparisons and interpretation. J Diabetes Sci Technol. 2008;2(6):1139–1146. doi:10.1177/193229680800200623
  • Woolcott OO, Bergman RN. Relative fat mass (RFM) as a new estimator of whole-body fat percentage ─ A cross-sectional study in American adult individuals. Sci Rep. 2018;8(1):10980. doi:10.1038/s41598-018-29362-1
  • Guzmán-León AE, Velarde AG, Vidal-Salas M, Urquijo-Ruiz LG, Caraveo-Gutiérrez LA, Valencia ME. External validation of the relative fat mass (RFM) index in adults from north-west Mexico using different reference methods. PLoS One. 2019;14(12):e0226767. doi:10.1371/journal.pone.0226767
  • Suthahar N, Wang K, Zwartkruis VW, et al. Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population. Eur J Intern Med. 2023;109:73–78. doi:10.1016/j.ejim.2022.12.024
  • Andreasson A, Carlsson AC, Önnerhag K, Hagström H. Predictive capacity for mortality and severe liver disease of the relative fat mass algorithm. Clin Gastroenterol Hepatol. 2019;17(12):2619–2620. doi:10.1016/j.cgh.2018.11.026
  • Suthahar N, Meems LMG, Withaar C, et al. Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND. Sci Rep. 2022;12(1):147. doi:10.1038/s41598-021-02409-6
  • Kobo O, Leiba R, Avizohar O, Karban A. Relative fat mass (RFM) as abdominal obesity criterion for metabolic syndrome. Eur J Intern Med. 2019;63:e9–e11
  • Wang N, Zhang K, Han B, et al. Follicle stimulating hormone, its novel association with sex hormone binding globulin in men and postmenopausal women. Endocrine. 2017;56(3):649–657. doi:10.1007/s12020-017-1272-y
  • Wang B, Zhang W, Chen C, et al. Lead exposure and impaired glucose homeostasis in Chinese adults: a repeated measures study with 5 years of follow-up. Ecotoxicol Environ Saf. 2022;243:113953. doi:10.1016/j.ecoenv.2022.113953
  • Wan H, Wang Y, Xiang Q, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118. doi:10.1186/s12933-020-01095-4
  • Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–959. doi:10.1001/jama.2013.168118
  • Farrell GC, Chitturi S, Lau GKK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007;22(6):775–777. doi:10.1111/j.1440-1746.2007.05002.x
  • Lu J, Bi Y, Wang T, et al. The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population: results of the REACTION study. Int J Cardiol. 2014;172(2):388–394. doi:10.1016/j.ijcard.2014.01.073
  • Haufs MG, Zöllner YF. Waist-Hip ratio more appropriate than body mass index. Dtsch Arztebl Int. 2020;117(39):659. doi:10.3238/arztebl.2020.0659a
  • Jayedi A, Soltani S, Zargar MS, Khan TA, Shab-Bidar S. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. BMJ. 2020;370:m3324. doi:10.1136/bmj.m3324
  • Lee CMY, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. 2008;61(7):646–653. doi:10.1016/j.jclinepi.2007.08.012
  • Koloverou E, Panagiotakos DB, Kyrou I, et al. Visceral adiposity index outperforms common anthropometric indices in predicting 10-year diabetes risk: results from the ATTICA study. Diabetes Metab Res Rev. 2019;35(6):e3161. doi:10.1002/dmrr.3161
  • Amato MC, Giordano C. Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol. 2014;2014:730827. doi:10.1155/2014/730827
  • Zhang Y, Li B, Liu N, Wang P, He J. Evaluation of different anthropometric indicators for screening for non-alcoholic fatty liver disease in elderly individuals. Int J Endocrinol. 2021;2021:6678755. doi:10.1155/2021/6678755
  • Dai H, Wang W, Chen R, Chen Z, Lu Y, Yuan H. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab. 2017;14:49. doi:10.1186/s12986-017-0206-2
  • Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275–286. doi:10.1111/j.1467-789X.2011.00952.x
  • Ke J-F, Wang J-W, Lu J-X, Zhang Z-H, Liu Y, Li L-X. Waist-to-height ratio has a stronger association with cardiovascular risks than waist circumference, waist-Hip ratio and body mass index in type 2 diabetes. Diabetes Res Clin Pract. 2022;183:109151. doi:10.1016/j.diabres.2021.109151
  • Mehran L, Amouzegar A, Fanaei SM, Masoumi S, Azizi F. Anthropometric measures and risk of all-cause and cardiovascular mortality: an 18 years follow-up. Obes Res Clin Pract. 2022;16(1):63–71. doi:10.1016/j.orcp.2021.12.004
  • Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(2):247–269. doi:10.1017/S0954422410000144
  • Lee K, Sung J-A, Kim J-S, Park T-J. The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans. Diabetes Metab Res Rev. 2009;25(2):150–155. doi:10.1002/dmrr.924
  • Razzouk L, Muntner P. Ethnic, gender, and age-related differences in patients with the metabolic syndrome. Curr Hypertens Rep. 2009;11(2):127–132. doi:10.1007/s11906-009-0023-8